Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Recombinant DNA Technology Market Size Share Forecast 2024

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Overview:

Recombinant DNA technology is quickly changing the way we research and learn about our planet. Originally developed for experiments in labs, Recombinant DNA is now used in a wide variety of projects ranging from developing better animal models to finding better ways to fight disease. This fast-paced science is changing the way we hunt for answers to everything from cancer to aging and beyond. Originally developed for genetic engineering, Recombinant DNA technology now allows scientists to produce precise copies of any desired product. The global recombinant DNA technology market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global recombinant DNA technology market during the forecast period, owing to the expansion of the biopharmaceutical industry.

Market Drivers:

Technological advancements in genomics are expected to drive growth of the global recombinant DNA technology market during the forecast period. Genomics refers to the study of the full genetic complement of an organism where it employs DNA sequencing, recombinant DNA, and bioinformatics to sequence, assemble, and analyze the structure of genomes. For instance, in June 2021, QIAGEN launched QIAprep&amp CRISPR Kit and CRISPR Q-Primer Solutions the enable researchers to analyze edited genetic material with robust speed and efficiency, in order to determine how their interventions have changed the function of the DNA sequence in the discussion. Hence, such factors are expected to drive the growth of the global recombinant DNA technology market during the forecast period. Moreover, the expansion of the biopharmaceutical industry is expected to propel the global recombinant DNA technology market growth over the forecast period.

Market Restraint:

Stringent scientific, ethical, and regulatory challenges are expected to hamper the global recombinant DNA technology market growth over the forecast period.

Regional Insights:

Among regions, North America is expected to witness significant growth in the global recombinant DNA technology market during the forecast period. This is owing to the presence of various biopharmaceutical companies such as Thermo Fisher Scientific, Inc., Biogen, Inc., and Pfizer Inc. across the region. Moreover, Asia Pacific is expected to register a robust growth rate, owing to rising investment in R&D activities related to genomics in the region.

Competitive Section:

Major companies involved in the global recombinant DNA technology market are Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen, Inc., and Monsanto Company.

Key features of the study:

• This report provides in-depth analysis of recombinant DNA technology market and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 - 2025), considering 2016 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global recombinant DNA technology market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen, Inc., and Monsanto Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global recombinant DNA technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the recombinant DNA technology market

Detailed Segmentation:

• Global Recombinant DNA Technology Market, By Product Type:
o Recombinant Protein Drugs
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
o Vaccines
o Genetically Modified Crops
o Expression Systems
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
o Cell and Gene Therapy
o Gene Editing

• Global Recombinant DNA Technology Market, By Application:
o Therapeutics
o Agriculture
o Research

• Global Recombinant DNA Technology Market, By Geography:
o North America
 By Product Type:
 Recombinant Protein Drugs
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
 Vaccines
 Genetically Modified Crops
 Expression Systems
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
 Cell and Gene Therapy
 Gene Editing
 By Application:
 Therapeutics
 Agriculture
 Research
 By Country:
 U.S.
 Canada
o Latin America
 By Product Type:
 Recombinant Protein Drugs
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
 Vaccines
 Genetically Modified Crops
 Expression Systems
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
 Cell and Gene Therapy
 Gene Editing
 By Application:
 Therapeutics
 Agriculture
 Research
 By Country:
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Europe
 By Product Type:
 Recombinant Protein Drugs
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
 Vaccines
 Genetically Modified Crops
 Expression Systems
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
 Cell and Gene Therapy
 Gene Editing
 By Application:
 Therapeutics
 Agriculture
 Research
 By Country:
 Germany
 U.K.
 France
 Italy
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 By Product Type:
 Recombinant Protein Drugs
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
 Vaccines
 Genetically Modified Crops
 Expression Systems
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
 Cell and Gene Therapy
 Gene Editing
 By Application:
 Therapeutics
 Agriculture
 Research
 By Country:
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 By Product Type:
 Recombinant Protein Drugs
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
 Vaccines
 Genetically Modified Crops
 Expression Systems
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
 Cell and Gene Therapy
 Gene Editing
 By Application:
 Therapeutics
 Agriculture
 Research
 By Country:
 GCC
 Israel
 Rest of Middle East
o Africa
 By Product Type:
 Recombinant Protein Drugs
 Insulin
 Human Growth Hormone
 Erythropoietin
 Interferon
 Blood Factors
 Colony Stimulating Factors
 Fusion Proteins
 Others
 Vaccines
 Genetically Modified Crops
 Expression Systems
 Prokaryotic Cells
 Mammalian Cells
 Yeats
 Insect
 Others
 Cell and Gene Therapy
 Gene Editing
 By Application:
 Therapeutics
 Agriculture
 Research
 By Country:
 South Africa
 Central Africa
 North Africa

• Company Profiles

o Thermo Fisher Scientific, Inc.*
 Company Overview
 Product Portfolio
 Key Developments
 Financial Overview
 Market Strategies
o Biogen, Inc.
o Sanofi Pasteur
o Merck & Co., Inc.
o Pfizer, Inc.
o Profacgen
o Amgen, Inc.
o Monsanto Company
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Application
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
? Industry Trends
o Regulatory Scenario
o Key Highlights
o PEST Analysis
o Epidemiology
o Impact Analysis
o PORTER's Analysis
4. Global Recombinant DNA Technology Market, By Product Type, 2015 - 2025, (US$ Billion)
o Introduction
? Market Share Analysis, 2015 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Recombinant Protein Drugs
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
? Segment Trends
? Insulin
? Human Growth Hormone
? Erythropoietin
? Interferon
? Blood Factors
? Colony Stimulating Factors
? Fusion Proteins
? Others
o Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
o Genetically Modified Crops
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
o Expression Systems
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
? Segment Trends
? Prokaryotic Cells
? Mammalian Cells
? Yeats
? Insect
? Others
o Cell and Gene Therapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
o Gene Editing
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
5. Global Recombinant DNA Technology Market, By Application, 2015 - 2025, (US$ Billion)
o Introduction
? Market Share Analysis, 2015 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Therapeutics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
o Agriculture
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
o Research
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Billion)
6. Global Recombinant DNA Technology Market, By Region, 2015 - 2025, (US$ Billion)
o Introduction
? Market Share Analysis, By Region, 2015 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
o North America
? Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Billion)
? U.S.
? Canada
o Latin America
? Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Billion)
? Brazil
? Mexico
? Argentina
? Rest of Latin America
o Europe
? Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Billion)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Billion)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Middle East
? Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Billion)
? GCC
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Application, 2015 - 2025, (US$ Billion)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Billion)
? South Africa
? Central Africa
? North Africa
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Thermo Fisher Scientific, Inc.*
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overviews
? Market Strategies
? Biogen, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overviews
? Market Strategies
? Sanofi Pasteur
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overviews
? Market Strategies
? Merck & Co., Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overviews
? Market Strategies
? Pfizer, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overviews
? Market Strategies
? Profacgen
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overviews
? Market Strategies
? Amgen, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overviews
? Market Strategies
? Monsanto Company
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overviews
? Market Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 38 market data tables and 26 figures on "Recombinant DNA Technology Market - Global forecast to 2025".

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us